NX Pharmagen
Louisville, US
Healthtech
Founders & leadership
FM
Fred MermelsteinDirector
RS
Robert SaundersDirector
BB
Brian BrohmanExecutive Officer, Director
AE
Alan EzrinDirector
Reported raises · per SEC filings
Form D private placements$590KraisedOct 2022 · 19 investors · Biotechnology
Rule 506(b)$486KraisedAug 2020 · 13 investors · Other Health Care
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.